Filing Flows › Comparisons › INDV vs ACAD
Indivior Pharmaceuticals vs Acadia Pharmaceuticals: INDV and ACAD compared
Indivior Pharmaceuticals is the larger company: $356M of revenue in its latest quarter (Q3 2026) against $342M for Acadia Pharmaceuticals (Q3 2026). Acadia Pharmaceuticals is growing faster (+23% against +13% a year earlier). Indivior Pharmaceuticals is more profitable, with an operating margin of 50.6% against 21.0%.
Where the money goes: INDV and ACAD
Indivior Pharmaceuticals (INDV) · Q3 2026
Indivior Pharmaceuticals, Q3 2026: revenue $356M (+13% year over year), operating margin 50.6%, net earnings $137M, operating cash flow $97.0M. The chart follows the revenue to costs, profit and cash.
Acadia Pharmaceuticals (ACAD) · Q3 2026
Acadia Pharmaceuticals, Q3 2026: revenue $342M (+23% year over year), operating margin 21.0%, net earnings $53.5M, operating cash flow $11.5M. The chart follows the revenue to costs, profit and cash.
| Indivior Pharmaceuticals (INDV) | Acadia Pharmaceuticals (ACAD) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $356M | $342M |
| Revenue growth, Y/Y | +13% | +23% |
| Gross margin | 85.7% | — |
| Operating margin | 50.6% | 21.0% |
| Net earnings | $137M | $53.5M |
| Net margin | 38.5% | 15.6% |
| Operating cash flow | $97.0M | $11.5M |
| Free cash flow | $83.0M | $10.3M |
| Market value | $4.4B | $3.7B |
| P/E | 10.1× | 10.3× |
| Analysts’ mean target | $49.50 | $30.68 |
Where the revenue comes from
Acadia Pharmaceuticals
- Nuplazid: $202M (59%)
- Daybue: $140M (41%)
Questions
Which is bigger, Indivior Pharmaceuticals or Acadia Pharmaceuticals?
Indivior Pharmaceuticals is the larger company: $356M of revenue in its latest quarter (Q3 2026) against $342M for Acadia Pharmaceuticals (Q3 2026).
Is Indivior Pharmaceuticals or Acadia Pharmaceuticals growing faster?
Acadia Pharmaceuticals is growing faster (+23% against +13% a year earlier).
Which is more profitable, Indivior Pharmaceuticals or Acadia Pharmaceuticals?
Indivior Pharmaceuticals is more profitable, with an operating margin of 50.6% against 21.0%.
More: Indivior Pharmaceuticals earnings · how Indivior Pharmaceuticals makes money · Acadia Pharmaceuticals earnings · how Acadia Pharmaceuticals makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Oct 29, 2026; 10-Q filed Nov 5, 2026). Fiscal quarters can end on different dates. Not investment advice.